Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6126
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.48B
| $10K | ﹤0.01% |
990
-828
| -46% | -$8.4K |
2015 Q1
1 quarter
|
|
6127
Kamada
KMDA
$453M
| $10K | ﹤0.01% |
2,812
-298
| -10% | -$1.3K |
2013 Q4
6 quarters
|
|
6128
Minerva Neurosciences
NERV
$138M
| $10K | ﹤0.01% |
209
-72
| -26% | -$3.07K |
2014 Q3
3 quarters
|
|
6129
Peoples Bancorp of North Carolina
PEBK
$239M
| $10K | ﹤0.01% |
615
| – | – |
2013 Q4
6 quarters
|
|
|
NYMX
6130
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $10K | ﹤0.01% |
7,509
+6,940
| +1,220% | +$9.7K |
2013 Q3
7 quarters
|
|
|
RADA
6131
DELISTED
Rada Electronic Industries Ltd
RADA
| $10K | ﹤0.01% |
2,574
-415
| -14% | -$1.96K |
2014 Q1
5 quarters
|
|
|
CVRS
6132
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $10K | ﹤0.01% |
+2,789
| New | +$11.9K |
2015 Q2
0 quarters
|
|
|
CZFC
6133
DELISTED
Citizens First Corporation
CZFC
| $10K | ﹤0.01% |
806
| – | – |
2014 Q1
5 quarters
|
|
|
DTRM
6134
DELISTED
Determine, Inc. Common Stock
DTRM
| $10K | ﹤0.01% |
1,863
+1
| +0.1% | +$6 |
2013 Q4
6 quarters
|
|
|
PRKR
6135
DELISTED
Parkervision Inc
PRKR
| $10K | ﹤0.01% |
2,770
+588
| +27% | +$3.24K |
2013 Q2
8 quarters
|
|
|
GRR
6136
DELISTED
Asia Tigers Fund
GRR
| $10K | ﹤0.01% |
921
-1,619
| -64% | -$18.8K |
2013 Q4
6 quarters
|
|
|
UCP
6137
DELISTED
UCP, Inc.
UCP
| $10K | ﹤0.01% |
1,292
| – | – |
2013 Q3
7 quarters
|
|
|
SPHS
6138
DELISTED
Sophiris Bio, Inc.
SPHS
| $10K | ﹤0.01% |
12,529
+12,501
| +44,646% | +$10.6K |
2013 Q4
6 quarters
|
|
6139
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| $10K | ﹤0.01% |
5,325
+4,700
| +752% | +$9.96K |
2013 Q4
6 quarters
|
|
6140
Banco Bradesco
BBDO
$42.1B
| $9K | ﹤0.01% |
1,934
+1,757
| +993% | +$9.37K |
2013 Q2
8 quarters
|
|
6141
Century Casinos
CNTY
$23.3M
| $9K | ﹤0.01% |
1,418
+621
| +78% | +$3.71K |
2013 Q4
6 quarters
|
|
6142
DELISTED
Evoke Pharma
EVOK
| $9K | ﹤0.01% |
12
+5
| +71% | +$4.26K |
2014 Q4
2 quarters
|
|
6143
Quest Resource Holding
QRHC
$28.5M
| $9K | ﹤0.01% |
+1,027
| New | +$9.76K |
2015 Q2
0 quarters
|
|
6144
TOP Ships
TOPS
$3.6M
| – | – |
0
| – | – |
2013 Q4
6 quarters
|
|
6145
Ur-Energy
URG
$372M
| $9K | ﹤0.01% |
11,443
-55,223
| -83% | -$50.5K |
2013 Q4
6 quarters
|
|
6146
Value Line
VALU
$406M
| $9K | ﹤0.01% |
900
| – | – |
2014 Q1
5 quarters
|
|
|
MIXT
6147
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $9K | ﹤0.01% |
1,057
+449
| +74% | +$3.25K |
2013 Q4
6 quarters
|
|
|
CHIE
6148
DELISTED
Global X MSCI China Energy ETF
CHIE
| $9K | ﹤0.01% |
627
| – | – |
2015 Q1
1 quarter
|
|
|
INDT
6149
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $9K | ﹤0.01% |
300
| – | – |
2013 Q4
6 quarters
|
|
|
SUMR
6150
DELISTED
Summer Infant, Inc.
SUMR
| $9K | ﹤0.01% |
498
-1,412
| -74% | -$33.5K |
2013 Q4
6 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.